Sophie Borot

Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study

Bertrand Cariou, Samy Hadjadj, Matthieu Wargny et al. · Diabetologia · 2020 · 830 citations · Full text

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 286 citations · Full text

Metabolic Syndrome, Type 1, Diabetes Management +9

Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial

Pierre‐Yves Benhamou, Sylvia Franc, Yves Reznik et al. · The Lancet Digital Health · 2019 · 209 citations · Full text

Gastric Electrical Stimulation Reduces Refractory Vomiting in a Randomized Crossover Trial

Philippe Ducrotté, Benoît Coffin, Bruno Bonaz et al. · Gastroenterology · 2019 · 149 citations

Functional Gastrointestinal Disorder, Gastroenterology, Randomized Crossover Trial +5

Temozolomide treatment can improve overall survival in aggressive pituitary tumors and pituitary carcinomas

Hélène Lasolle, Christine Cortet, Frédéric Castinetti et al. · European Journal of Endocrinology · 2017 · 135 citations